Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494869 · ClinicalTrials.gov registry record · NA
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
A NA study of High Risk for Developing Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02494869 is a NA study of High Risk for Developing Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02494869, a NA study of High Risk for Developing Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to look at the effect that different amounts of progressive exercise training has on risk factors associated with developing breast cancer. These risk factors include exercise capacity, body weight, and body composition, as well as the expression of certain genes and levels of inflammatory factors in your breast tissue. The participant will be instructed to self-report the session information to ExOnc staff at or before their next scheduled visit. If the participant's next scheduled visit is greater than 72 hours following an unsupervised session, ExOnc staff may reach out to the participant to retrieve the session information. Unsupervised session details will be source documented by ExOnc staff.
Conditions Studied
Interventions
- OTHER Blood draw
- BEHAVIORAL Nonlinear Aerobic Training
- OTHER Height, Weight, BMI measure
- OTHER Cardiopulmonary exercise test
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02494869
The ClinicalTrials.gov registry entry for NCT02494869 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High Risk for Developing Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Blood draw is the first listed.
NCT02494869 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02494869 about?
NCT02494869 is a clinical study titled "Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer". This study is being done to look at the effect that different amounts of progressive exercise training has on risk factors associated with developing breast cancer. These risk factors include exercise capacity, body weight, and body composition, as well as the expression of certain genes and levels ...
What is the current status of trial NCT02494869?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2015-07. Estimated completion is 2026-07.
What conditions does trial NCT02494869 study?
This clinical trial studies the following conditions: High Risk for Developing Breast Cancer.
What interventions are being tested in trial NCT02494869?
The interventions under investigation include: Blood draw (OTHER), Nonlinear Aerobic Training (BEHAVIORAL), Height, Weight, BMI measure (OTHER), Cardiopulmonary exercise test (OTHER).
Who is sponsoring clinical trial NCT02494869?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02494869 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.